ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00326768
Recruitment Status : Completed
First Posted : May 17, 2006
Last Update Posted : December 28, 2017
Sponsor:
Information provided by:
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2007
  Study Completion Date : August 2007